APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Protease Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antiretroviral Protease Inhibitor Industry Growth and Trends Forecast to 2032

Report ID 17396655012 January 202690 pages

Choose your research edition.

Industry ResearchAntiretroviral Protease Inhibitor Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Protease Inhibitor Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Antiretroviral Protease Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Protease Inhibitor Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Protease Inhibitor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiretroviral Protease Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Protease Inhibitor include Merck, AbbVie, Tibotec, Genentech, Inc., Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiretroviral Protease Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiretroviral Protease Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiretroviral Protease Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiretroviral Protease Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiretroviral Protease Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiretroviral Protease Inhibitor Market by Company

Merck

AbbVie

Tibotec

Genentech, Inc.

Bristol-Myers Squibb

Boehringer Ingelheim

Antiretroviral Protease Inhibitor Segment by Type

Amino Peptidase Inhibitor

Cysteine Protease Inhibitors

Metallo-Protease Inhibitors

Serine Protease Inhibitors

Aspartic Protease Inhibitors

Others

Antiretroviral Protease Inhibitor Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Others

Antiretroviral Protease Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Protease Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Protease Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Protease Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiretroviral Protease Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiretroviral Protease Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Amino Peptidase Inhibitor Table 2. Major Company of Cysteine Protease Inhibitors Table 3. Major Company of Metallo-Protease Inhibitors Table 4. Major Company of Serine Protease Inhibitors Table 5. Major Company of Aspartic Protease Inhibitors Table 6. Major Company of Others Table 7. Global Antiretroviral Protease Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 9. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 10. Global Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 11. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Type (2021-2026) Table 12. Global Antiretroviral Protease Inhibitor Price by Type (2021-2026) & (US$/Unit) Table 13. Global Antiretroviral Protease Inhibitor Sales by Type (2027-2032) & (K Units) Table 14. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 15. Global Antiretroviral Protease Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 16. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Type (2027-2032) Table 17. Global Antiretroviral Protease Inhibitor Price by Type (2027-2032) & (US$/Unit) Table 18. North America Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 19. North America Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 21. Europe Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 25. Latin America Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 28. Antiretroviral Protease Inhibitor Industry Trends Table 29. Antiretroviral Protease Inhibitor Industry Drivers Table 30. Antiretroviral Protease Inhibitor Industry Opportunities and Challenges Table 31. Antiretroviral Protease Inhibitor Industry Restraints Table 32. Global Antiretroviral Protease Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Antiretroviral Protease Inhibitor Revenue Market Share by Company (2021-2026) Table 34. Global Antiretroviral Protease Inhibitor Sales by Company (2021-2026) & (K Units) Table 35. Global Antiretroviral Protease Inhibitor Sales Share by Company (2021-2026) Table 36. Global Antiretroviral Protease Inhibitor Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Antiretroviral Protease Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Antiretroviral Protease Inhibitor Major Company Production Sites and Headquarters Table 39. Global Antiretroviral Protease Inhibitor Company, Product Type & Application Table 40. Global Antiretroviral Protease Inhibitor Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Antiretroviral Protease Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Antiretroviral Protease Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Antiretroviral Protease Inhibitor Sales by Region (2021-2026) & (K Units) Table 45. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 46. Global Antiretroviral Protease Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 47. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Region (2021-2026) Table 48. Global Antiretroviral Protease Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Antiretroviral Protease Inhibitor Sales by Region (2027-2032) & (K Units) Table 50. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 51. Global Antiretroviral Protease Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 52. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Region (2027-2032) Table 53. Global Antiretroviral Protease Inhibitor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Antiretroviral Protease Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 56. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 57. Global Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 58. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Application (2021-2026) Table 59. Global Antiretroviral Protease Inhibitor Price by Application (2021-2026) & (US$/Unit) Table 60. Global Antiretroviral Protease Inhibitor Sales by Application (2027-2032) & (K Units) Table 61. Global Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 62. Global Antiretroviral Protease Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 63. Global Antiretroviral Protease Inhibitor Sales Market Share in Value by Application (2027-2032) Table 64. Global Antiretroviral Protease Inhibitor Price by Application (2027-2032) & (US$/Unit) Table 65. North America Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 66. North America Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 68. Europe Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 72. Latin America Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Antiretroviral Protease Inhibitor Product Portfolio Table 79. Merck Recent Development Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. AbbVie Antiretroviral Protease Inhibitor Product Portfolio Table 84. AbbVie Recent Development Table 85. Tibotec Company Information Table 86. Tibotec Business Overview Table 87. Tibotec Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Tibotec Antiretroviral Protease Inhibitor Product Portfolio Table 89. Tibotec Recent Development Table 90. Genentech, Inc. Company Information Table 91. Genentech, Inc. Business Overview Table 92. Genentech, Inc. Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Genentech, Inc. Antiretroviral Protease Inhibitor Product Portfolio Table 94. Genentech, Inc. Recent Development Table 95. Bristol-Myers Squibb Company Information Table 96. Bristol-Myers Squibb Business Overview Table 97. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product Portfolio Table 99. Bristol-Myers Squibb Recent Development Table 100. Boehringer Ingelheim Company Information Table 101. Boehringer Ingelheim Business Overview Table 102. Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Boehringer Ingelheim Antiretroviral Protease Inhibitor Product Portfolio Table 104. Boehringer Ingelheim Recent Development Table 105. North America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 106. North America Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 107. North America Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2026) Table 108. North America Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 109. North America Antiretroviral Protease Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 110. North America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. North America Antiretroviral Protease Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 112. North America Antiretroviral Protease Inhibitor Market Share by Country (2021-2026) Table 113. North America Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. North America Antiretroviral Protease Inhibitor Market Share Forecast by Country (2027-2032) Table 115. Europe Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. Europe Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 117. Europe Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2026) Table 118. Europe Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 119. Europe Antiretroviral Protease Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 120. Europe Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Europe Antiretroviral Protease Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 122. Europe Antiretroviral Protease Inhibitor Market Share by Country (2021-2026) Table 123. Europe Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Europe Antiretroviral Protease Inhibitor Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 127. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2026) Table 128. Asia-Pacific Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 129. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Antiretroviral Protease Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 132. Asia-Pacific Antiretroviral Protease Inhibitor Market Share by Country (2021-2026) Table 133. Asia-Pacific Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Asia-Pacific Antiretroviral Protease Inhibitor Market Share Forecast by Country (2027-2032) Table 135. Latin America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Latin America Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 137. Latin America Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2026) Table 138. Latin America Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 139. Latin America Antiretroviral Protease Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 140. Latin America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Latin America Antiretroviral Protease Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 142. Latin America Antiretroviral Protease Inhibitor Market Share by Country (2021-2026) Table 143. Latin America Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Latin America Antiretroviral Protease Inhibitor Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 147. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2026) Table 148. Middle East and Africa Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032) & (K Units) Table 149. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Antiretroviral Protease Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 152. Middle East and Africa Antiretroviral Protease Inhibitor Market Share by Country (2021-2026) Table 153. Middle East and Africa Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Middle East and Africa Antiretroviral Protease Inhibitor Market Share Forecast by Country (2027-2032) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Antiretroviral Protease Inhibitor Distributors List Table 158. Antiretroviral Protease Inhibitor Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Antiretroviral Protease Inhibitor Image Figure 2. Global Antiretroviral Protease Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiretroviral Protease Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiretroviral Protease Inhibitor Sales (2021-2032) & (K Units) Figure 5. Amino Peptidase Inhibitor Image Figure 6. Global Amino Peptidase Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cysteine Protease Inhibitors Image Figure 8. Global Cysteine Protease Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Metallo-Protease Inhibitors Image Figure 10. Global Metallo-Protease Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Serine Protease Inhibitors Image Figure 12. Global Serine Protease Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 13. Aspartic Protease Inhibitors Image Figure 14. Global Aspartic Protease Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Antiretroviral Protease Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Antiretroviral Protease Inhibitor Market Share by Type 2025 VS 2032 Figure 19. North America Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. North America Antiretroviral Protease Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Europe Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type in 2025 Figure 22. Europe Antiretroviral Protease Inhibitor Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share in Value by Type in 2025 Figure 25. Latin America Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Antiretroviral Protease Inhibitor Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Antiretroviral Protease Inhibitor Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Pharmacy Image Figure 32. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Online Pharmacy Image Figure 34. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 35. Retail Pharmacy Image Figure 36. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Antiretroviral Protease Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Antiretroviral Protease Inhibitor Market Share by Application 2025 VS 2032 Figure 41. North America Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application in 2025 Figure 42. North America Antiretroviral Protease Inhibitor Sales Market Share in Value by Application in 2025 Figure 43. Europe Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application in 2025 Figure 44. Europe Antiretroviral Protease Inhibitor Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share in Value by Application in 2025 Figure 47. Latin America Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Antiretroviral Protease Inhibitor Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share in Value by Application in 2025 Figure 51. North America Antiretroviral Protease Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Antiretroviral Protease Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Antiretroviral Protease Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Antiretroviral Protease Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Antiretroviral Protease Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Antiretroviral Protease Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Antiretroviral Protease Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Antiretroviral Protease Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Antiretroviral Protease Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antiretroviral Protease Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Antiretroviral Protease Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Antiretroviral Protease Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Antiretroviral Protease Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Antiretroviral Protease Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Antiretroviral Protease Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Antiretroviral Protease Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Antiretroviral Protease Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Antiretroviral Protease Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Antiretroviral Protease Inhibitor Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Antiretroviral Protease Inhibitor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Peptidase Inhibitor
  • Cysteine Protease Inhibitors
  • Metallo-Protease Inhibitors
  • Serine Protease Inhibitors
  • Aspartic Protease Inhibitors
  • Others
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Merck
  • AbbVie
  • Tibotec
  • Genentech, Inc.
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiretroviral Protease Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiretroviral Protease Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiretroviral Protease Inhibitor Market by Type
  6. 1.3.1 Amino Peptidase Inhibitor
  7. 1.3.2 Cysteine Protease Inhibitors
  8. 1.3.3 Metallo-Protease Inhibitors
  9. 1.3.4 Serine Protease Inhibitors
  10. 1.3.5 Aspartic Protease Inhibitors
  11. 1.3.6 Others
  12. 1.4 Global Antiretroviral Protease Inhibitor Market Size by Type
  13. 1.4.1 Global Antiretroviral Protease Inhibitor Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Antiretroviral Protease Inhibitor Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Antiretroviral Protease Inhibitor Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Antiretroviral Protease Inhibitor Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Antiretroviral Protease Inhibitor Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Antiretroviral Protease Inhibitor Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Antiretroviral Protease Inhibitor Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Antiretroviral Protease Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiretroviral Protease Inhibitor Industry Trends
  2. 2.2 Antiretroviral Protease Inhibitor Industry Drivers
  3. 2.3 Antiretroviral Protease Inhibitor Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Protease Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiretroviral Protease Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiretroviral Protease Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by Antiretroviral Protease Inhibitor Price (2021-2026)
  4. 3.4 Global Antiretroviral Protease Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiretroviral Protease Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global Antiretroviral Protease Inhibitor Company, Product Type & Application
  7. 3.7 Global Antiretroviral Protease Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiretroviral Protease Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiretroviral Protease Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiretroviral Protease Inhibitor Tier 1, Tier 2, and Tier 3
4 Antiretroviral Protease Inhibitor Regional Status and Outlook
  1. 4.1 Global Antiretroviral Protease Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiretroviral Protease Inhibitor Historic Market Size by Region
  3. 4.2.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiretroviral Protease Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiretroviral Protease Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiretroviral Protease Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiretroviral Protease Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiretroviral Protease Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiretroviral Protease Inhibitor by Application
  1. 5.1 Antiretroviral Protease Inhibitor Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antiretroviral Protease Inhibitor Market Size by Application
  7. 5.2.1 Global Antiretroviral Protease Inhibitor Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antiretroviral Protease Inhibitor Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antiretroviral Protease Inhibitor Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antiretroviral Protease Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antiretroviral Protease Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antiretroviral Protease Inhibitor Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antiretroviral Protease Inhibitor Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antiretroviral Protease Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Antiretroviral Protease Inhibitor Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Antiretroviral Protease Inhibitor Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Tibotec
  14. 6.3.1 Tibotec Company Information
  15. 6.3.2 Tibotec Business Overview
  16. 6.3.3 Tibotec Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tibotec Antiretroviral Protease Inhibitor Product Portfolio
  18. 6.3.5 Tibotec Recent Developments
  19. 6.4 Genentech, Inc.
  20. 6.4.1 Genentech, Inc. Company Information
  21. 6.4.2 Genentech, Inc. Business Overview
  22. 6.4.3 Genentech, Inc. Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genentech, Inc. Antiretroviral Protease Inhibitor Product Portfolio
  24. 6.4.5 Genentech, Inc. Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Antiretroviral Protease Inhibitor Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Antiretroviral Protease Inhibitor Sales by Country
  2. 7.1.1 North America Antiretroviral Protease Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiretroviral Protease Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiretroviral Protease Inhibitor Market Size by Country
  6. 7.2.1 North America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiretroviral Protease Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiretroviral Protease Inhibitor Sales by Country
  2. 8.1.1 Europe Antiretroviral Protease Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiretroviral Protease Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiretroviral Protease Inhibitor Market Size by Country
  6. 8.2.1 Europe Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiretroviral Protease Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiretroviral Protease Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific Antiretroviral Protease Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiretroviral Protease Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiretroviral Protease Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiretroviral Protease Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiretroviral Protease Inhibitor Sales by Country
  2. 10.1.1 South America Antiretroviral Protease Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiretroviral Protease Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiretroviral Protease Inhibitor Market Size by Country
  6. 10.2.1 South America Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiretroviral Protease Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa Antiretroviral Protease Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiretroviral Protease Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiretroviral Protease Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa Antiretroviral Protease Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiretroviral Protease Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiretroviral Protease Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiretroviral Protease Inhibitor Value Chain Analysis
  2. 12.1.1 Antiretroviral Protease Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiretroviral Protease Inhibitor Production Mode & Process
  7. 12.2 Antiretroviral Protease Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiretroviral Protease Inhibitor Distributors
  10. 12.2.3 Antiretroviral Protease Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst